1.Relationship between the morbidity of pterygium and the duration of ultraviolet rays exposure in Sanya, China.
Qi-chang YAN ; Xin-ling WANG ; Quan-hao BAI ; Wei WANG ; Qian GAO ; Jin-song ZHANG ; Yang LIU ; Rong LIU
Chinese Medical Journal 2006;119(15):1308-1310
Adult
;
Aged
;
Aged, 80 and over
;
Female
;
Humans
;
Male
;
Middle Aged
;
Morbidity
;
Prospective Studies
;
Pterygium
;
etiology
;
Time Factors
;
Ultraviolet Rays
;
adverse effects
2.The Involvement of Adult Stem Cells Originated from Bone Marrow in the Pathogenesis of Pterygia.
Young Soo SONG ; Yang Hwan RYU ; Suk Rae CHOI ; Jae Chan KIM
Yonsei Medical Journal 2005;46(5):687-692
Pterygium is a proliferative disease. Recent research has reported that stem cells are involved in the pathogenesis of various proliferative diseases, including solid tumors and diabetic proliferate vitreoretinopathy. In previous literature, we hypothesized that adult stem cells originated from bone marrow were involved in the pathogenesis of pterygium. We proved this by immunohistochemical staining with various stem cell markers. The staining showed adult stem cells in the pterygium. c-kit positive cells were observed primarily in the stroma, and some cells were also found in the basal epithelium. AC133 and CD34 positive cells were primarily found in the basal epithelium and were ovoid shaped, similar to the c-kit cells. However, some cells were found in vascular endothelium. STRO-1 positive cells were found mainly in the stroma and were spindle shaped. In recurrent pterygium, cells were more scattered and the expression pattern was denser. Therefore, we suggest a new theory of pterygium pathogenesis. Inflammation caused by environmental factors triggers the abnormal production of some growth factors and cytokines in order to recover from cellular damage. If these healing signals are excessive, limbal basal cells will be changed to abnormally-altered pterygial cells. The excessive wound healing process and remnant altered cells result in recurrence using the same mechanism.
Stem Cells/*physiology
;
Pterygium/*etiology
;
Proto-Oncogene Proteins c-kit/analysis
;
Peptides/analysis
;
Middle Aged
;
Humans
;
Glycoproteins/analysis
;
Bone Marrow Cells/*physiology
;
Antigens, CD34/analysis
;
Antigens, CD/analysis
3.Scleral necrosis and infection 15 years following pterygium excision.
K G Au EONG ; P S TSENG ; A S LIM
Singapore medical journal 1995;36(2):232-234
Scleral necrosis and infection are serious late complications of pterygium treatment and are difficult to manage. We describe a 70-year-old Chinese male who presented with scleral necrosis and Pseudomonas aeruginosa infection 15 years after the excision of a pterygium. The infection was treated early and aggressively with intensive topical and intravenous antibiotics and the thin necrotic sclera was reinforced with a donor scleral patch graft when the scleral infection was clinically controlled. The integrity of the globe was maintained by a thin layer of sclera anterior to the graft after the graft gradually shrunk in size and retracted posteriorly. The eye was saved from possible scleral perforation and endophthalmitis. This case is reported to highlight the importance of early aggressive treatment of infection and the value of prophylactic repair of scleral necrosis in the management of these late complications of pterygium treatment.
Administration, Topical
;
Aged
;
Anti-Bacterial Agents
;
Drug Therapy, Combination
;
administration & dosage
;
therapeutic use
;
Humans
;
Injections, Intravenous
;
Male
;
Necrosis
;
Pseudomonas Infections
;
drug therapy
;
Pseudomonas aeruginosa
;
Pterygium
;
surgery
;
Sclera
;
pathology
;
transplantation
;
Scleral Diseases
;
drug therapy
;
microbiology
;
Surgical Wound Infection
;
drug therapy
;
etiology
4.Clinical Features, Predisposing Factors, and Treatment Outcomes of Scleritis in the Korean Population.
Seong Joon AHN ; Joo Youn OH ; Mee Kum KIM ; Jin Hak LEE ; Won Ryang WEE
Korean Journal of Ophthalmology 2010;24(6):331-335
PURPOSE: To evaluate the clinical features, associated factors, and treatment outcomes of scleritis in the Korean population. METHODS: Medical records were retrospectively reviewed for 94 eyes of 76 patients with scleritis. Clinical features of scleritis, including systemic disease, presence of microorganisms, serologic markers, history of previous ocular surgery, and use of immunosuppressants were investigated and compared amongst the subtypes of scleritis. Treatment outcomes were evaluated using best corrected visual acuity (BCVA) and time to scleritis remission. RESULTS: Nodular scleritis was the most common form observed, followed by necrotizing scleritis with inflammation, diffuse scleritis, and necrotizing scleritis without inflammation, respectively. A total of 16 of 76 patients (21.1%) had connective tissue diseases. Eleven cases (14.5%) had infectious scleritis, of which bacteria (54.5%) and fungi (45.5%) were the causative microorganisms. Thirty-three patients (43.4%) had previous ocular surgery, mostly pterygium excision. Notably, a history of pterygium excision was significantly associated with development of necrotizing and infectious scleritis (odds ratio [OR], 399 and 10.1; p < 0.001 and 0.002, respectively). In addition, patients with necrotizing scleritis were more likely to have infectious scleritis (OR, 11.7; p = 0.001). BCVA after treatment and time to remission also showed significant differences among the different scleritis subtypes. Systemic immunosuppression was required in addition to steroids for treating diffuse and necrotizing scleritis. CONCLUSIONS: Careful taking of patient history including previous pterygium excision should be performed, especially in patients with necrotizing and infectious scleritis. In addition, evaluation of microbiological infection can be crucial for patients with necrotizing scleritis and history of pterygium excision.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
*Asian Continental Ancestry Group
;
Bacterial Infections
;
Child
;
Eyeglasses
;
Female
;
Humans
;
Male
;
Medical Records
;
Middle Aged
;
Mycoses
;
Postoperative Period
;
Pterygium/surgery
;
Retrospective Studies
;
Scleritis/classification/ethnology/*etiology/*surgery
;
Treatment Outcome
;
Visual Acuity
;
Young Adult
5.Successful Treatment of Infectious Scleritis by Pseudomonas aeruginosa with Autologous Perichondrium Graft of Conchal Cartilage.
Woong Sun YOO ; Che Ron KIM ; Byung Jae KIM ; Seong Ki AHN ; Seong Wook SEO ; Ji Myong YOO ; Seong Jae KIM
Yonsei Medical Journal 2015;56(6):1738-1741
Infectious scleritis by Pseudomonas aeruginosa is a well-known vision-threatening disease. In particular, scleral trauma following pterygium surgery may increase the risk of sclera inflammation. Surgical debridement and repair is necessary in patients who do not respond to medical treatments, such as topical and intravenous antibiotics. We reports herein the effectiveness of an autologous perichondrium conchal cartilage graft for infectious scleritis caused by Pseudomonas aeruginosa. This procedure was performed on four eyes of four patients with infectious scleritis who had previously undergone pterygium surgery at Gyeongsang National University Hospital (GNUH), Jinju, Korea from December 2011 to May 2012. Pseudomonas aeruginosa was identified in cultures of necrotic scleral lesion before surgery. The conchal cartilage perichondrium graft was transplanted, and a conjunctival flap was created on the scleral lesion. The autologous perichondrium conchal cartilage graft was successful and visual outcome was stable in all patients, with no reports of graft failure or infection recurrence. In conclusion, autologous perichondrium conchal cartilage graft may be effective in surgical management of Pseudomonal infectious scleritis when non-surgical medical treatment is ineffective. Further studies in larger, diverse populations are warranted to establish the effectiveness of the procedure.
Anti-Bacterial Agents/therapeutic use
;
Autografts
;
Cartilage/surgery
;
Communicable Diseases
;
Debridement
;
Eye Infections, Bacterial/etiology/*therapy
;
Female
;
Humans
;
Ophthalmologic Surgical Procedures
;
Postoperative Complications
;
Pseudomonas Infections/microbiology/*therapy
;
Pseudomonas aeruginosa/*isolation & purification
;
Pterygium/surgery
;
Republic of Korea
;
Sclera/*surgery/transplantation
;
Scleritis/microbiology/*therapy
;
Surgical Wound Infection/microbiology/*therapy
;
Transplantation, Autologous
;
Treatment Outcome